Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-006983
Filing Date
2024-11-08
Accepted
2024-11-08 15:56:05
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q qron_10q.htm   iXBRL 10-Q 1110925
2 TERMINATION NOTICE qron_ex1038.htm EX-10.38 6364
3 NOTICE TO ARIEL SCIENTIFIC INNOVATIONS qron_ex1039.htm EX-10.39 6181
4 CERTIFICATION qron_ex31.htm EX-31 11632
5 CERTIFICATION qron_ex32.htm EX-32 4024
11 qron_ex1038img4.jpg GRAPHIC 14211
12 qron_ex1039img1.jpg GRAPHIC 14202
  Complete submission text file 0001477932-24-006983.txt   5941747

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA qron-20240930.xsd EX-101.SCH 61614
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE qron-20240930_lab.xml EX-101.LAB 301251
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qron-20240930_cal.xml EX-101.CAL 38871
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qron-20240930_pre.xml EX-101.PRE 280658
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qron-20240930_def.xml EX-101.DEF 191511
74 EXTRACTED XBRL INSTANCE DOCUMENT qron_10q_htm.xml XML 1181811
Mailing Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101
Business Address 28-10 JACKSON AVENUE, #26N LONG ISLAND CITY NY 11101 212-945-2080
Qrons Inc. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55800 | Film No.: 241440310
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)